Hard to Treat Diseases (Hard to Treat Diseases) Price-to-Operating-Cash-Flow : (As of Jun. 19, 2024)

View and export this data going back to . Start your Free Trial

What is Hard to Treat Diseases Price-to-Operating-Cash-Flow?

As of today (2024-06-19), Hard to Treat Diseases's share price is $1.0E-5. Hard to Treat Diseases does not have enough years/quarters to calculate the Cash Flow from Operations per share for the trailing twelve months (TTM) ended in . 20. Therefore GuruFocus does not calculate Price-to-Operating-Cash-Flow Ratio at this moment.

The historical rank and industry rank for Hard to Treat Diseases's Price-to-Operating-Cash-Flow or its related term are showing as below:

HTDS's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.955
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Hard to Treat Diseases's Cash Flow from Operations per share for the three months ended in . 20 was $0.00.

Hard to Treat Diseases Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Hard to Treat Diseases's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hard to Treat Diseases Price-to-Operating-Cash-Flow Chart

Hard to Treat Diseases Annual Data

Trend

Price-to-Operating-Cash-Flow

Hard to Treat Diseases Quarterly Data

Price-to-Operating-Cash-Flow

Competitive Comparison of Hard to Treat Diseases's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Hard to Treat Diseases's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hard to Treat Diseases's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hard to Treat Diseases's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Hard to Treat Diseases's Price-to-Operating-Cash-Flow falls into.

Hard to Treat Diseases Price-to-Operating-Cash-Flow Calculation

Hard to Treat Diseases's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.0E-5	/
	=

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Hard to Treat Diseases Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Hard to Treat Diseases's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Hard to Treat Diseases (Hard to Treat Diseases) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hard to Treat Diseases Inc (OTCPK:HTDS) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

2655 Ulmerton Road, No. 338, Clearwater, FL, USA, 33762

Website

http://www.htdsmedical.com

Hard to Treat Diseases Inc operates medical and cosmetics company in Europe, and Mainland China. It is s also in the process of developing its own stem cell bank.

Hard to Treat Diseases (Hard to Treat Diseases) Headlines

No Headlines